Skip to content
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Search
Read about Endologix
in the news
Embrace the evidence.
The Latest:
Jul 9
Endologix Announces that Scott Huennekens Joins Board of Directors
See Release
All News
Archives
All
2025
2024
2023
2022
2021
Jul 9
Endologix Announces that Scott Huennekens Joins Board of Directors
Mar 20
Endologix Announces 1000 patients treated with the DETOUR™ System.
Mar 3
Endologix Appoints Andrew Davis as Chief Commercial Officer
Jan 7
Endologix Announces Leadership Transition
Nov 5
Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
